Menu

Experience

Jason Kent

    • Travere Therapeutics – $316 Million Convertible Note Offering 


    • Vuori Secures $400 Million Investment From SoftBank Vision Fund 2 


    • Reneo Pharmaceuticals – $94 Million IPO 


    • Mirum Inks $210 Million Funding Arrangement + Closes Follow-On Offering 


    • Sazerac to Acquire Paul Masson Grande Amber Brandy From Constellation Brands 


    • Neurocrine Partners With Takeda to Address Psychiatric Disorders 


    • Sazerac to Acquire Whiskey Brands and Distillery From Brown-Forman 


    • Cooley advises Ascus Biosciences on $46M Series B Round 


    • Sazerac Acquires Beverage Brands from Diageo for 550 Million 


    • Sazerac Investment in John Distilleries 


    • Mirum Pharmaceuticals - $75 Million IPO 


    • Neurocrine Biosciences, Inc: $290 Million Follow-On Offering 


    • Competitor Group, Inc: Event and Acquisition Agreements for Rock 'n' Roll Marathon Series 


    • Baby Tula LLC: $82 Million Sale to Compass Diversified Holdings 


    • Sazerac to Acquire Southern Comfort + Tuaca for $544 Million 


    • Retrophin, Inc: $245 Million Sale of Review Voucher to Sanofi 


    • Celladon Initial Public Offering 


    • Hot Topic $600 Million Sale to Sycamore Partners 


    • Spruce Biosciences – $130 Million IPO